Physician Assistant · Ravenna, OH
NPI
1992254981
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6847 N Chestnut St Ste 210
Ravenna, OH, 44266
Phone (330) 297-6060
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
189 services
Medicare patients, 2024
137
Average age 74
Drug cost, 2024
$115K
934 prescriptions
Company payments, 2025
$962
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephany Indorf was code 99232 (hospital e&m - subsequent), 71 times for 44 patients. In total Stephany Indorf billed 189 services in 8 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 71 | 44 | $49.76 | $3,533 |
| 99204 Office E&M - New | Office | 48 | 48 | $97.28 | $4,670 |
| 99214 Office E&M - Established | Office | 44 | 40 | $73.38 | $3,229 |
By year: 2022 $10K for 167 services; 2023 $13K for 205 services; 2024 $13K for 189 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephany Indorf prescribed most often to Medicare patients was Omeprazole, with 210 prescriptions and refills. In total Stephany Indorf wrote 934 Medicare prescriptions that cost $115K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 210 | 280 | 55 | $2,080 |
| Pantoprazole Sodium Generic | 170 | 249 | 56 | $1,209 |
| Famotidine Generic | 122 | 153 | 27 | $1,454 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 81 | 81 | 78 | $1,228 |
| Loperamide Loperamide Hcl | 60 | 62 | 13 | $1,354 |
| Linzess Linaclotide | 47 | 71 | 13 | $37K |
| Dicyclomine Hcl Generic | 36 | 36 | 15 | $408 |
| Cholestyramine Cholestyramine (With Sugar) | 23 | 37 | Under 11 | $990 |
| Golytely Peg3350/Sod Sulf,bicarb,cl/Kcl | 17 | 17 | 17 | $416 |
| Lubiprostone Generic | 16 | 16 | Under 11 | $1,168 |
| Amitriptyline Hcl Generic | 14 | 18 | Under 11 | $182 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $203 |
| Mesalamine Generic | 14 | 16 | Under 11 | $3,517 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 13 | 13 | 13 | $188 |
| Budesonide Ec Budesonide | 12 | 16 | Under 11 | $3,391 |
Brand drugs: 119 claims; generic drugs: 815 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephany Indorf $962 ($962 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $388.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 11 | $184 |
| QOL Medical, LLC | 3 | $85.5 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $59.69 |
| Aimmune Therapeutics, Inc. | 3 | $59.18 |
| Celltrion USA Inc. 068270.KS | 3 | $44.11 |
| Janssen Biotech, Inc. JNJ | 2 | $38.73 |
| Ferring Pharmaceuticals Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $23.55 |
| Novo Nordisk Inc NVO | 1 | $18.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.